Meeting Banner
Abstract #1867

Combination normobaric oxygen and methylene blue treatment delays the progression of ischemic penumbra into infarct and promotes behavioral recovery

Pavel Rodriguez 1,2 , Jiang Zhao 2 , Brian Milman 3 , Lora Talley Watts 2 , and Timothy Q. Duong 2

1 Department of Radiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States, 2 Research Imaging Institute, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States, 3 School of Medicine, University of Texas Health Science Center at San Antonio, Texas, United States

We previously reported that methylene blue (MB) an energy enhancing and antioxidant reduces infarct volume in 60-mins and permanent MCAO in rats. This study investigated the combination therapy of MB and normobaric oxygen (NBO) treatment in ischemic stroke. We hypothesized that MB+NBO treatment delays infarct growth and salvages more tissue than NBO + Vehicle treatment alone in a 60-min MCAO model in rats and that longitudinal MB treatment promotes faster motor functional behavioral recovery.

This abstract and the presentation materials are available to members only; a login is required.

Join Here